ABOUT THE PRODUCT
Confirm mdx is a genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions. It addresses prostate biopsy sampling error and the false-negative biopsy dilemma, improving patient stratification and risk assessment. The test is supported by Level 1 Evidence and can be used with at-home collection.
Information is owner-confirmed
Last updated 4 months ago
Price range
Other products/services from Confirm mdx
GPS (Genomic Prostate Score)
Biotechnology
N/A
Confirm mdx
United States (US)